The next board meeting for Ultragenyx Pharmaceutical Inc. is on 09 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare ConferenceSee details
Ultragenyx Pharmaceutical Inc. - RARE - stock price prediction, stock price target, analyst ratings from 20 analysts
Ultragenyx Pharmaceutical Inc. has a share price target of US$ 87, revenue growth forecast of 17.4%, and profit growth estimate of 10.3% for FY25, based on top 20 analyst calls.